1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine, 95.0%, 5g

1-(4-Chloro-5-methyl-pyrimidin-2-yl)-[1,4]diazepane hydrochloride, 95.0%, 1g

3-Aminobenzamide, 98.0%, 25g

C8-Alkyne-dU-CEP, ≥95%, 1 g, plastic packaging.

6-Bromo-1,3-dihydro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isobenzofuran, 1g

4-(4-Bromo-3-fluorobenzyl)thiomorpholine 1,1-dioxide, 97%, 1g

L-2-(4-Chlorophenyl)glycine>98.0%(HPLC)(T)5g

4,7-Dibromo-2,1,3-benzothiadiazole, 95.0%, 100g

4-Aminobicyclo[2.2.1]heptane-1-carboxylic acid hydrochloride, 95.0%, 250mg

(3-Chloro-4-fluorophenyl)(4-fluoro-4-((((5-methylpyrimidin-2-yl)methyl)amino)methyl)piperidin-1-yl)methanone, 98.0%, 10mg

2,6-Dichloro-9-ethyl-9H-purine, 97%, 250mg

3-Fluoro-4-methoxy (1,3-dioxolan-2-ylmethyl)benzene, 97.0%, 1g

4-allyl-5-[1-(3-chlorophenoxy)ethyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 1g